APO RESEARCH · REPORT
Blood Glucose Testing
Blood glucose testing, also known as blood glucose monitoring, is one of the main tools involved in controlling diabetes.
Product & engineering
Understand the product.
Blood glucose testing, also known as blood glucose monitoring, is one of the main tools involved in controlling diabetes.
Blood glucose testing is the process used to measure the concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter.
A blood test involves pricking your finger with a small needle called a lancet, drawing a drop of blood from the finger and applying it to a test strip that has been engaged into a blood glucose meter.
Blood glucose test strips, lancet and blood glucose meter are together used for blood glucose testing. But Blood glucose test strips are most used, occupies about 85% market of blood glucose testing.
Selected research
Market Outlook & Growth Opportunities
Global Blood Glucose Testing Market Outlook and Growth Opportunities 2026
Market perspective
Blood glucose testing, also known as blood glucose monitoring, is one of the main tools involved in controlling diabetes.
Blood glucose testing is the process used to measure the concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter.
A blood test involves pricking your finger with a small needle called a lancet, drawing a drop of blood from the finger and applying it to a test strip that has been engaged into a blood glucose meter.
Read the full market overview
Blood glucose test strips, lancet and blood glucose meter are together used for blood glucose testing. But Blood glucose test strips are most used, occupies about 85% market of blood glucose testing.
Market competition is intense. Roche, LIFESCAN, Abbott and Ascensia, etc. are the leaders of the industry, with about 54% market shares.
North America is the largest consumption place, with a consumption market share nearly 31%. Following North America, Europe is the second largest consumption place with the consumption market share of 29%.
This report provides an overview of the global Blood Glucose Testing market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Blood Glucose Testing and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Blood Glucose Testing sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Blood Glucose Testing market size, projected growth trends, production technologies, key applications, and end-use industries.
Blood Glucose Testing Segment by Company
Roche
LIFESCAN
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
Nipro Dagnostics
77 Elektronika
AgaMatrix
Infopia
ALL Medicus
Terumo
SANNUO
Yicheng
Yuwell
Blood Glucose Testing Segment by Type
Glucose Oxidase
Glucose Dehydrogenase
Others
Blood Glucose Testing Segment by Application
Hospital
Clinic
Household
Blood Glucose Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Blood Glucose Testing status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Blood Glucose Testing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Blood Glucose Testing significant trends, drivers, influence factors in global and regions.
6. To analyze Blood Glucose Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Glucose Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Glucose Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Glucose Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Blood Glucose Testing market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Glucose Testing industry.
Chapter 3: Detailed analysis of Blood Glucose Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Blood Glucose Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Blood Glucose Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Glucose Oxidase
- Glucose Dehydrogenase
- Others
Applications
- Hospital
- Clinic
- Household
Companies covered
- Roche
- LIFESCAN
- Abbott
- Ascensia
- ARKRAY
- I-SENS
- Omron
- B. Braun
- Nipro Dagnostics
- 77 Elektronika
- AgaMatrix
- Infopia
- ALL Medicus
- Terumo
- SANNUO
- Yicheng
- Yuwell
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Blood Glucose Testing Sales Value (2021-2032)
- 1.2.2 Global Blood Glucose Testing Sales Volume (2021-2032)
- 1.2.3 Global Blood Glucose Testing Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Blood Glucose Testing Market Dynamics
- 2.1 Blood Glucose Testing Industry Trends
- 2.2 Blood Glucose Testing Industry Drivers
- 2.3 Blood Glucose Testing Industry Opportunities and Challenges
- 2.4 Blood Glucose Testing Industry Restraints
3 Blood Glucose Testing Market by Company
- 3.1 Global Blood Glucose Testing Company Revenue Ranking in 2025
- 3.2 Global Blood Glucose Testing Revenue by Company (2021-2026)
- 3.3 Global Blood Glucose Testing Sales Volume by Company (2021-2026)
- 3.4 Global Blood Glucose Testing Average Price by Company (2021-2026)
- 3.5 Global Blood Glucose Testing Company Ranking (2024-2026)
- 3.6 Global Blood Glucose Testing Company Manufacturing Base and Headquarters
- 3.7 Global Blood Glucose Testing Company Product Type and Application
- 3.8 Global Blood Glucose Testing Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Blood Glucose Testing Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Blood Glucose Testing Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Blood Glucose Testing Market by Type
- 4.1 Blood Glucose Testing Type Introduction
- 4.1.1 Glucose Oxidase
- 4.1.2 Glucose Dehydrogenase
- 4.1.3 Others
- 4.2 Global Blood Glucose Testing Sales Volume by Type
- 4.2.1 Global Blood Glucose Testing Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Blood Glucose Testing Sales Volume by Type (2021-2032)
- 4.2.3 Global Blood Glucose Testing Sales Volume Share by Type (2021-2032)
- 4.3 Global Blood Glucose Testing Sales Value by Type
- 4.3.1 Global Blood Glucose Testing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Blood Glucose Testing Sales Value by Type (2021-2032)
- 4.3.3 Global Blood Glucose Testing Sales Value Share by Type (2021-2032)
5 Blood Glucose Testing Market by Application
- 5.1 Blood Glucose Testing Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Household
- 5.2 Global Blood Glucose Testing Sales Volume by Application
- 5.2.1 Global Blood Glucose Testing Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Blood Glucose Testing Sales Volume by Application (2021-2032)
- 5.2.3 Global Blood Glucose Testing Sales Volume Share by Application (2021-2032)
- 5.3 Global Blood Glucose Testing Sales Value by Application
- 5.3.1 Global Blood Glucose Testing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Blood Glucose Testing Sales Value by Application (2021-2032)
- 5.3.3 Global Blood Glucose Testing Sales Value Share by Application (2021-2032)
6 Blood Glucose Testing Regional Sales and Value Analysis
- 6.1 Global Blood Glucose Testing Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Blood Glucose Testing Sales by Region (2021-2032)
- 6.2.1 Global Blood Glucose Testing Sales by Region: 2021-2026
- 6.2.2 Global Blood Glucose Testing Sales by Region (2027-2032)
- 6.3 Global Blood Glucose Testing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Blood Glucose Testing Sales Value by Region (2021-2032)
- 6.4.1 Global Blood Glucose Testing Sales Value by Region: 2021-2026
- 6.4.2 Global Blood Glucose Testing Sales Value by Region (2027-2032)
- 6.5 Global Blood Glucose Testing Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Blood Glucose Testing Sales Value (2021-2032)
- 6.6.2 North America Blood Glucose Testing Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Blood Glucose Testing Sales Value (2021-2032)
- 6.7.2 Europe Blood Glucose Testing Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Blood Glucose Testing Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Blood Glucose Testing Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Blood Glucose Testing Sales Value (2021-2032)
- 6.9.2 South America Blood Glucose Testing Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Blood Glucose Testing Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Blood Glucose Testing Sales Value Share by Country, 2025 VS 2032
7 Blood Glucose Testing Country-level Sales and Value Analysis
- 7.1 Global Blood Glucose Testing Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Blood Glucose Testing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Blood Glucose Testing Sales by Country (2021-2032)
- 7.3.1 Global Blood Glucose Testing Sales by Country (2021-2026)
- 7.3.2 Global Blood Glucose Testing Sales by Country (2027-2032)
- 7.4 Global Blood Glucose Testing Sales Value by Country (2021-2032)
- 7.4.1 Global Blood Glucose Testing Sales Value by Country (2021-2026)
- 7.4.2 Global Blood Glucose Testing Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.9.2 France Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.16.2 China Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.19.2 India Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Blood Glucose Testing Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Blood Glucose Testing Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Blood Glucose Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Roche
- 8.1.1 Roche Company Information
- 8.1.2 Roche Business Overview
- 8.1.3 Roche Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Roche Blood Glucose Testing Product Portfolio
- 8.1.5 Roche Recent Developments
- 8.2 LIFESCAN
- 8.2.1 LIFESCAN Company Information
- 8.2.2 LIFESCAN Business Overview
- 8.2.3 LIFESCAN Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.2.4 LIFESCAN Blood Glucose Testing Product Portfolio
- 8.2.5 LIFESCAN Recent Developments
- 8.3 Abbott
- 8.3.1 Abbott Company Information
- 8.3.2 Abbott Business Overview
- 8.3.3 Abbott Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Abbott Blood Glucose Testing Product Portfolio
- 8.3.5 Abbott Recent Developments
- 8.4 Ascensia
- 8.4.1 Ascensia Company Information
- 8.4.2 Ascensia Business Overview
- 8.4.3 Ascensia Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Ascensia Blood Glucose Testing Product Portfolio
- 8.4.5 Ascensia Recent Developments
- 8.5 ARKRAY
- 8.5.1 ARKRAY Company Information
- 8.5.2 ARKRAY Business Overview
- 8.5.3 ARKRAY Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.5.4 ARKRAY Blood Glucose Testing Product Portfolio
- 8.5.5 ARKRAY Recent Developments
- 8.6 I-SENS
- 8.6.1 I-SENS Company Information
- 8.6.2 I-SENS Business Overview
- 8.6.3 I-SENS Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.6.4 I-SENS Blood Glucose Testing Product Portfolio
- 8.6.5 I-SENS Recent Developments
- 8.7 Omron
- 8.7.1 Omron Company Information
- 8.7.2 Omron Business Overview
- 8.7.3 Omron Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Omron Blood Glucose Testing Product Portfolio
- 8.7.5 Omron Recent Developments
- 8.8 B. Braun
- 8.8.1 B. Braun Company Information
- 8.8.2 B. Braun Business Overview
- 8.8.3 B. Braun Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.8.4 B. Braun Blood Glucose Testing Product Portfolio
- 8.8.5 B. Braun Recent Developments
- 8.9 Nipro Dagnostics
- 8.9.1 Nipro Dagnostics Company Information
- 8.9.2 Nipro Dagnostics Business Overview
- 8.9.3 Nipro Dagnostics Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Nipro Dagnostics Blood Glucose Testing Product Portfolio
- 8.9.5 Nipro Dagnostics Recent Developments
- 8.10 77 Elektronika
- 8.10.1 77 Elektronika Company Information
- 8.10.2 77 Elektronika Business Overview
- 8.10.3 77 Elektronika Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.10.4 77 Elektronika Blood Glucose Testing Product Portfolio
- 8.10.5 77 Elektronika Recent Developments
- 8.11 AgaMatrix
- 8.11.1 AgaMatrix Company Information
- 8.11.2 AgaMatrix Business Overview
- 8.11.3 AgaMatrix Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.11.4 AgaMatrix Blood Glucose Testing Product Portfolio
- 8.11.5 AgaMatrix Recent Developments
- 8.12 Infopia
- 8.12.1 Infopia Company Information
- 8.12.2 Infopia Business Overview
- 8.12.3 Infopia Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Infopia Blood Glucose Testing Product Portfolio
- 8.12.5 Infopia Recent Developments
- 8.13 ALL Medicus
- 8.13.1 ALL Medicus Company Information
- 8.13.2 ALL Medicus Business Overview
- 8.13.3 ALL Medicus Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.13.4 ALL Medicus Blood Glucose Testing Product Portfolio
- 8.13.5 ALL Medicus Recent Developments
- 8.14 Terumo
- 8.14.1 Terumo Company Information
- 8.14.2 Terumo Business Overview
- 8.14.3 Terumo Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Terumo Blood Glucose Testing Product Portfolio
- 8.14.5 Terumo Recent Developments
- 8.15 SANNUO
- 8.15.1 SANNUO Company Information
- 8.15.2 SANNUO Business Overview
- 8.15.3 SANNUO Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.15.4 SANNUO Blood Glucose Testing Product Portfolio
- 8.15.5 SANNUO Recent Developments
- 8.16 Yicheng
- 8.16.1 Yicheng Company Information
- 8.16.2 Yicheng Business Overview
- 8.16.3 Yicheng Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Yicheng Blood Glucose Testing Product Portfolio
- 8.16.5 Yicheng Recent Developments
- 8.17 Yuwell
- 8.17.1 Yuwell Company Information
- 8.17.2 Yuwell Business Overview
- 8.17.3 Yuwell Blood Glucose Testing Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Yuwell Blood Glucose Testing Product Portfolio
- 8.17.5 Yuwell Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Blood Glucose Testing Value Chain Analysis
- 9.1.1 Blood Glucose Testing Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Blood Glucose Testing Sales Mode & Process
- 9.2 Blood Glucose Testing Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Blood Glucose Testing Distributors
- 9.2.3 Blood Glucose Testing Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst